Personalized Ovarian Cancer Disease Surveillance and Detection of Candidate Therapeutic Drug Target in Circulating Tumor DNA

Retrospective studies have demonstrated that nearly 50% of patients with ovarian cancer with normal cancer antigen 125 (CA125) levels have persistent disease; however, prospectively distinguishing between patients is currently impossible. Here, we demonstrate that for one patient, with the first rep...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Martignetti, John A, Camacho-Vanegas, Olga, Priedigkeit, Nolan, Camacho, Catalina, Pereira, Elena, Lin, Li, Garnar-Wortzel, Leopold, Miller, Dagny, Losic, Bojan, Shah, Hardik, Liao, Jun, Ma, Jian, Lahiri, Pratik, Chee, Mark, Schadt, Eric, Dottino, Peter
Format: Artigo
Langue:Inglês
Publié: Neoplasia Press Inc. 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3924545/
https://ncbi.nlm.nih.gov/pubmed/24563622
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires